Immunotoxicity of soluble β-glucans induced by indomethacin treatment

FEMS Immunology and Medical Microbiology

Volumn 21, Issue 3, 1998, Pages 171-179

  Yoshioka, Shoichi ^a   Ohno, Naohito ^a   Miura, Toshihide ^a   Adachi, Yoshiyuki ^a   Yadomae, Toshiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Glucan; Indomethacin; Lethal toxicity; Systemic inflammatory response syndrome

Indexed keywords

BETA GLUCAN; GRIFOLAN; INDOMETACIN; SCHIZOPHYLLAN; ZYMOSAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNOTOXICITY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LETHALITY; MALE; MORTALITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-GLUCANS; COLONY-STIMULATING FACTORS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GLUCANS; INDOMETHACIN; INTERFERON TYPE II; INTERLEUKIN-6; MALE; MICE; MICE, INBRED ICR; SIZOFIRAN; SPLENOMEGALY;

EID: 0031871558     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00046-7     Document Type: Article

References (24)

1. Chihara, G., Maeda, Y.Y., Suga, T. and Hamuro, J. (1989) Lentinan as a host defense potentiator (HDP). Int. J. Immunother. V, 145-150.
2. Taguti, T., Kaneko, Y. and Chihara, G. (1988) Lentinan. Biotherapy 2, 509-521.
3. Fujimoto, S., Orita, K., Kondoh, T., Taguchi, T., Yoshida, K., Kimura, T., Ogawa, N. and Furue, H. (1988) Schizophyllan. Biotherapy 2, 500-508.
4. Furue, H. (1986) Biological characteristic of schizophyllan (SPG) and its clinical effects. Med. Immunol. 12, 65-77.
5. Yadomae, T. (1992) Immunopharmacological activity of β-glucan: structure-activity relationship in relation to various conformations. Jpn. J. Med. Mycol. 33, 267-277.
6. Hashimoto, T., Ohno, N., Adachi, Y. and Yadomae, T. (1997) Nitric oxide synthesis in murine peritoneal macrophages by fungal β-glucans. Biol. Pharm. Bull. 20, 1006-1009.
7. Tateishi, T., Ohno, N., Adachi, Y. and Yadomae, T. (1997) Increases in hematopoietic responses caused by β-glucans in mice. Biosci. Biotech. Biochem. 61, 1548-1553.
8. Adachi, Y., Ohno, N., Ohsawa, M., Oikawa, S. and Yadomae, T. (1990) Change of biological activities of (1→3)-β-D-glucan from Grifola frondosa upon molecular weight reduction by heat treatment. Chem. Pharm. Bull. 38, 477-481.
9. Aketagawa, J., Tanaka, S., Tamura, H. and Shibata, Y. (1993) Activation of limulus coagulation factor G by several (1→3)-β-D-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J. Biochem. 113, 683-686.
10. Saito, H., Yoshioka, Y., Uehara, N., Aketagawa, J., Tanaka, S. and Shibata, Y. (1991) Relationship between conformation and biological response for (1→3)-β-D-glucans in the activation of coagulation factor G from limulus amebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant. Carbohydr. Res. 217, 181-190.
11. Yadomae, T. and Ohno, N. (1996) Structure-activity relationship of immunomodulating (1→3)-β-D-glucan. Recent Res. Dev. Chem. Pharm. Sci. 1, 23-33.
12. Yoshioka, Y., Uehara, N. and Saito, H. (1992) Conformation-dependent change in antitumor activity of linear and branched (1→3)-β-D-glucans on the basis of conformational elucidation by carbon-13 nuclear magnetic resonance spectroscopy. Chem. Pharm. Bull. 40, 1221-1226.
13. Campanile, F., Giampietri, A., Grohmann, U., Belladonna, L.M., Fioretti, C.M. and Puccetti, P. (1996) Evidence for tumor necrosis factor a as mediator of toxicity of a cyclooxy-genase inhibitor in Gram-negative sepsis. Eur. J. Pharmacol. 307, 191-199.
14. Kunkel, L.S., Chensue, W.S. and Phan, H.S. (1986) Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol. 136, 186-192.
15. Tsuboi, I., Tanaka, H., Nakao, M., Shichijo, S. and Itoh, K. (1995) Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-γ and IL-2, in contrast to down-regulation of IL-6 production. Cytokine 7, 372-379.
16. 2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Cell. Immunol. 120, 61-74.
17. Ohno, N., Suzuki, I. and Yadomae, T. (1986) Structure and antitumor activity of a β-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395. Chem. Pharm. Bull. 34, 1362-1365.
18. Ohno, N., Adachi, Y., Suzuki, I., Sato, K., Oikawa, S. and Yadomae, T. (1986) Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa. Chem. Pharm. Bull. 34, 1709-1715.
19. Saito, K., Nishijima, M., Ohno, N., Yadomae, T. and Miyazaki, T. (1992) Structure and antitumor activity of the less-branched derivatives of alkali-soluble glucan isolated from Omphalia lapidescens. (Studies on fungal polysaccharide. XXXVIII). Chem. Pharm. Bull. 40, 261-263.
20. Pettipher, E.R. and Wimberly, D.J. (1994) Cyclooxygenase inhibitors enhance tumor necrosis factor production and mortality in murine endotoxic shock. Cytokine 5, 500-503.
21. Okamura, H., Kawaguchi, K., Shoji, K. and Kawada, Y. (1982) High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect. Immun. 38, 440-443.
22. Yoshimoto, T., Nakanishi, K., Hirose, S., Hiroishi, K., Okamura, H., Takemoto, Y., Kanamaru, A., Hada, T., Tamura, T., Kakishita, E. and Higashino, K. (1992) High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J. Immunol. 148, 3596-3603.
23. Bone, R.C. (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). J. Am. Med. Assoc. 268, 3452-3455.
24. Rangel-Frausto, M.S., Pittet, D., Costigan, M., Hwang, T., Davis, S.C. and Wenzel, P.R. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). J. Am. Med. Assoc. 273, 117-123.